Ask AI
ProCE Banner Activity

Evolving Paradigms in Hematologic Malignancies: Expert Insights on 6 Key Abstracts From EHA and ICML 2025

Conference Coverage
Clinical Thought

In this expert commentary, 2 leading hematology specialists review and discuss 6 pivotal abstracts recently presented at the annual European Hematology Association and International Conference on Malignant Lymphoma Congresses, highlighting key advances across lymphoid and leukemic malignancies.

Released: August 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Faculty Disclosure

Primary Author

Max S. Topp, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, Autolus, BMS, Incyte, KITE, Merck, Regeneron; researcher: AstraZeneca, Kite, Regeneron, Roche. 

Pier Luigi Zinzani, MD, PhD: consultant/advisor/speaker: AbbVie, AstraZeneca, BeOne, Bristol Myers Squibb, Gilead, Incyte, Janssen, Kyowa Kirin, Merck Sharp & Dohme, Novartis, Recordati, Roche, Sobi, Takeda.